What Caught Our Attention in the Investment World? – Week of June 6-10, 2022

By Kuldip K. Ambastha Novavax, Inc. (NVAX), a clinical-stage vaccine company, had its stock price fall by -17.2% per share on Thursday, June 9, 2022. (See past coverage if needed: “What Caught Our Attention in the Investment World? – Week of December 27-31, 2021; By Kuldip K. Ambastha.”) In 1Q2022, earnings per share plus total …

What Caught Our Attention in the Investment World? – Week of April 18-22, 2022

By Kuldip K. Ambastha On Wednesday, April 20, 2022, the stock price of Netflix, Inc. (NFLX), a subscription streaming service and production company, dropped by -35.1% per share. (See past coverage if needed: “What Caught Our Attention in the Investment World? – Week of July 15-19, 2019; By Anil K. Ambastha and Kuldip K. Ambastha.”) …

What Caught Our Attention in the Investment World? – Week of February 14-18, 2022

By Kuldip K. Ambastha Roblox Corporation (RBLX), an online gaming and entertainment platform which brings people together over common interests, is a company we have covered in the past. (See “What Caught Our Attention in the Investment World? – Week of November 8-12, 2021; By Kuldip K. Ambastha” and “What Caught Our Attention in the …

What Caught Our Attention in the Investment World? – Week of December 27-31, 2021

By Kuldip K. Ambastha Novavax, Inc. (NVAX), a clinical-stage vaccine company, had four negative daily returns and one positive daily return for its shares during this past trading week per the table displayed here. Worldwide, the coronavirus pandemic continues to be a serious public health issue, especially through the Delta and Omicron COVID-19 variants. Novavax …

What Caught Our Attention in the Investment World? – Week of December 20-23, 2021

By Kuldip K. Ambastha On Tuesday, December 21, 2021, the stock of Carnival Corporation & plc (CCL), a leisure travel company, delivered an +8.7% gain for the trading day. Investors cheered on the company’s plan to return to profitability, which includes an anticipated profit in the second half of 2022. The company expects that COVID-19’s …

What Caught Our Attention in the Investment World? – Week of December 13-17, 2021

By Kuldip K. Ambastha The stock of Accenture plc (ACN), a multinational professional services company which is strong in information technology (IT) services and consulting, was up by +6.7% for the trading day of Thursday, December 16, 2021. Accenture delivered impressive quarterly results for the past quarter, with earnings and revenues both surpassing estimates by …

What Caught Our Attention in the Investment World? – Week of November 8-12, 2021

By Kuldip K. Ambastha On Tuesday, November 9, 2021, shares of Roblox Corporation (RBLX), an online gaming and entertainment platform which brings people together over common interests, shot up by +42.2% for the trading day. (See What Caught Our Attention in the Investment World? – Week of March 8-12, 2021; By Kuldip K. Ambastha for …

What Caught Our Attention in the Investment World? – Week of November 1-5, 2021

By Kuldip K. Ambastha On Tuesday, November 2, 2021, Avis Budget Group, Inc. (CAR) returned +108.3% and Chegg, Inc. (CHGG) returned -48.8% for the trading day. Avis, a vehicle rental and mobility solutions company, delivered strong 3Q2021 results and has announced a pledge to expand into using electric vehicles in the future. Avis has benefited …

What Caught Our Attention in the Investment World? – Week of September 13-17, 2021

By Kuldip K. Ambastha During this past trading week, stocks in the casino sector suffered greatly. After positive daily returns on Monday, September 13, negative daily returns were mostly seen for the rest of the trading week for Las Vegas Sands Corporation (LVS) and Wynn Resorts, Limited (WYNN) per the table seen above (except for …

What Caught Our Attention in the Investment World? – Week of August 9-13, 2021

By Kuldip K. Ambastha BioNTech SE (BNTX) is aiming to become a leading biotechnology company with a main focus on individualized cancer medicine. The company has also been successful in offering an mRNA-based, two-shot coronavirus vaccine called BNT162b2 (aka: Comirnaty and Tozinameran), which has become increasingly important due to the rise of the highly contagious …